atopic dermatitis

Dr. Marlys Fassett Receives the 2024 DF Bristol Myers Squibb Psoriasis Research Award

Marlys Fassett, MD, PhD, has received the 2024 DF Bristol Myers Squibb Psoriasis Research Award (BMSRA) from the Dermatology Foundation. Dr. Fassett is the second recipient of this prestigious award for extraordinary mid-career investigators. The award comes with $100,000 funding each year for three years to support her research into the role the cytokine IL-31…

Atopic Dermatitis: Guidelines of Care

Dr. Cohen presented information about the updated guidelines from the American Academy of Dermatology (AAD) for topical, systemic, and phototherapy treatments for atopic dermatitis (AD).   First, Dr. Cohen discussed updated AAD guidelines for topical therapies. Moisturizers, calcineurin inhibitors, topical corticosteroids, topical phosphodiesterase-4 (PDE-4) inhibitors, and Janus kinase (JAK) inhibitors are strongly recommended. Dr. Cohen encouraged…

Establishment of an Immune-Cell Niche in Skin

Dr. Rosenblum presented his research that identified a novel immune cell niche and its possible clinical applications. First, Dr. Rosenblum discussed regulatory T cells (Tregs) and their role in skin disease. Autoimmune and inflammatory diseases result from disruption in the balance of autoreactive and regulatory cells. Tregs are a type of regulatory cell in the…

The Diversity of Skin

In March 2022, Dr. Callender received the Dermatology Foundation’s Clark W. Finnerud Award presented to an individual who “most skillfully blends clinical practice with writing and teaching dermatology, thereby serving as a mentor and role model.”

New Topical Therapies for Psoriasis and Atopic Dermatitis

Dr. Bhutani presented new topical therapies for psoriasis and atopic dermatitis, including tapinarof, roflumilast, and ruxolitinib.

OFF Label ON Children

Dr. Treat presented off-label uses of systemic medications for rare and common pediatric diseases.